Jie Zhao
About Jie Zhao
Jie Zhao is the Marketing Head of Rare Tumor at BeiGene in Beijing, China, with over a decade of experience in pharmaceutical marketing and a diverse educational background.
Current Title and Role at BeiGene
Jie Zhao is the Marketing Head of Rare Tumor at BeiGene, based in Beijing City, China. Since 2018, Jie Zhao has been leading the marketing efforts and launches of new products and indications within the rare tumor market. This role involves strategic planning, market analysis, and overseeing the execution of marketing campaigns aimed at positioning BeiGene as a leader in the rare tumor pharmaceutical sector.
Professional Experience in the Pharmaceutical Industry
Jie Zhao has over a decade of experience in marketing within the pharmaceutical industry. Prior to joining BeiGene, Jie Zhao held various positions at major pharmaceutical companies. Jie Zhao served as the New Product Launch Leader at Lundbeck from 2017 to 2018, and as a Marketing Manager at Pfizer from 2010 to 2017, both roles located in Beijing City, China. Additionally, Jie Zhao worked as a Brand Manager at Novartis and as a Senior Product Manager and District Sales Manager at Janssen Inc., accumulating a robust background in managing product performances and sales.
Educational Background
Jie Zhao has a diverse educational background combining traditional Chinese medicine, business administration, and English studies. Jie Zhao holds a Master's degree in Business Administration and Management from BiMBA at Peking University (2016-2018) and studied English at Beijing International Studies University (2001-2002). Furthermore, Jie Zhao completed a Bachelor's degree in Acupuncture and Oriental Medicine at Henan College of Traditional Chinese Medicine (1992-1997), demonstrating a strong foundation in both Western business practices and traditional Chinese medicine.
Career Contributions and Achievements
Throughout Jie Zhao's career, significant contributions have been made in the pharmaceutical marketing field. Jie Zhao has been instrumental in the successful launch of new products and indications in the rare tumor market since 2018. Jie Zhao's role has involved managing classic products to achieve excellent market performance, leveraging extensive experience and expertise to drive strategic initiatives and market growth in the highly specialized pharmaceutical sector.